Piper Sandler analyst David Westenberg lowered the firm’s price target on Exact Sciences (EXAS) to $75 from $85 following quarterly results. The firm keeps an Overweight rating on the shares.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Exact Sciences price target lowered to $70 from $75 at Wells Fargo
- Trump Media, broader market surge after Trump wins election: Morning Buzz
- Morning Movers: CVS Health surges and ODP sinks following Q3 results
- Exact Sciences price target lowered to $65 from $82 at Craig-Hallum
- Exact Sciences price target raised to $85 from $84 at Jefferies